Somatic TP53 variants frequently confound germ-line testing results.

Autor: Weitzel JN; Division of Clinical Cancer Genomics, City of Hope, Duarte, California, USA. jweitzel@coh.org., Chao EC; Ambry Genetics, Aliso Viejo, California, USA.; Department of Pediatrics, University of California, Irvine, Irvine, California, USA., Nehoray B; Division of Clinical Cancer Genomics, City of Hope, Duarte, California, USA., Van Tongeren LR; Division of Clinical Cancer Genomics, City of Hope, Duarte, California, USA., LaDuca H; Ambry Genetics, Aliso Viejo, California, USA., Blazer KR; Division of Clinical Cancer Genomics, City of Hope, Duarte, California, USA., Slavin T, Facmg DABMD; Division of Clinical Cancer Genomics, City of Hope, Duarte, California, USA., Pesaran T; Ambry Genetics, Aliso Viejo, California, USA., Rybak C; Division of Clinical Cancer Genomics, City of Hope, Duarte, California, USA., Solomon I; Division of Clinical Cancer Genomics, City of Hope, Duarte, California, USA., Niell-Swiller M; Division of Clinical Cancer Genomics, City of Hope, Duarte, California, USA., Dolinsky JS; Ambry Genetics, Aliso Viejo, California, USA., Castillo D; Division of Clinical Cancer Genomics, City of Hope, Duarte, California, USA., Elliott A; Ambry Genetics, Aliso Viejo, California, USA., Gau CL; Ambry Genetics, Aliso Viejo, California, USA., Speare V; Ambry Genetics, Aliso Viejo, California, USA., Jasperson K; Ambry Genetics, Aliso Viejo, California, USA.

Publikováno v: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2018 Aug; Vol. 20 (8), pp. 809-816. Date of Electronic Publication: 2017 Nov 30.